BB Biotech

مادة اعلانية

Latest Update: 24 Apr 2025 19:30 Abu Dhabi Time.

Market Status: Closed

BBZA

BB Biotech

28.95

EUR

0.000

0.00%

Open

28.30

Prev Close

28.95

PX_VOLUME

859

MARKET CAP (M)

DAY RANGE

28.30 - 28.95

52 WEEKS

24.35 - 44.15

Stock Statistics

Yearly Change

-31.85%

Listed Shares (Million)

Earnings Multiple

20.55

Average 30-day trading volume

241.91

Price-to-book ratio

0.68

Earnings Per Share

1.38

Previous Dividend Distribution

1.30

Dividend Yield

7.03%

Financial Summary

Quarterly
Annual

Income Statements

	Period Ending:	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023
Total Revenue		67.79	-148.49	-77.76	270.70	118.75	-39.04
Gross Profit
Operating Income		60.43	-155.95	-85.49	261.95	110.73	-46.71
Profit Margin		88.00	105.85	111.98	96.23	91.89	123.97

	Period Ending:	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Total Revenue		112.24	-166.08	-313.00	-344.55	739.93
Gross Profit
Operating Income		80.93	-200.73	-356.02	-403.76	692.13
Profit Margin		67.62	124.40	114.32	117.49	93.41

Balance Sheet

	Period Ending:	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023
Total Assets		2,407.40	2,506.19	2,709.42	2,828.01	2,637.15	2,520.74
Total Liabilities		121.11	277.23	322.49	353.99	313.94	306.64
Total Equity		2,286.29	2,228.96	2,386.94	2,474.02	2,323.22	2,214.10

	Period Ending:	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Total Assets		2,407.40	2,637.15	3,053.39	3,644.08	3,963.14
Total Liabilities		121.11	313.94	367.25	360.59	75.59
Total Equity		2,286.29	2,323.22	2,686.14	3,283.49	3,887.55

Cash Flows Statements - Coming Soon

* In Million of Euro Member Countries

Reminder: The financial information on this website is delayed information that are originates from certified data providers in the financial markets, who retain the rights and intellectual property of this data, absolving ADMN of any responsibility.